| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Affitech AS > News item |
Affitech raises NOK 86 million from private placement
By Sheri Kasprzak
New York, April 10 - Affitech AS said it concluded a NOK 86 million private placement.
The full terms of the deal could not be determined Monday, but the proceeds will be used for pre-clinical development of some of the company's oncology antibody therapeutic candidates.
The proceeds will also be used to accelerate some of the company's other clinical studies.
The investors included Teknoinvest, Ferd Venture, Four Seasons Venture, Braganza AS and Arendals Fossekompani.
Based in Oslo, Affitech is a biotechnology company focused on oncology drugs.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.